This inventor holds 5 USPTO granted patents. Top assignees: Societe Anonyme Dite: Hexachimie, Hexachimie, Societe Anonyme Dite: Hexachime. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bourg-la-Reine, FR (1976 - 1978)
- Garches, FR (1976 - 1979)
Company Filing History:
3 out of 5 
1 out of 10 
1 out of 2 Years Active: 1976-1979
Title: The Innovations of Jean-Claude Cognacq
Introduction
Jean-Claude Cognacq is a notable inventor based in Garches, France. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work primarily focuses on the development of compounds that have therapeutic applications.
Latest Patents
Among his latest patents, Cognacq has developed diazepine derivatives, specifically 6-cyclopropyl-1,3-dihydro-1-methyl-5-phenyl-2-oxo-2H-thieno [2,3-e] diazepine. This invention includes pharmaceutically acceptable non-toxic acid addition salts, which are particularly useful in treating gastro-duodenal disorders. Additionally, he has patented a p-acetamidophenyl diethylaminoacetate, a derivative that is soluble in water and provides stable aqueous solutions. This compound rapidly releases para-acetamidophenol in the organism, enhancing its therapeutic efficacy.
Career Highlights
Cognacq has worked with several companies throughout his career, including Hexachimie and Hexachime. His innovative work in the pharmaceutical industry has positioned him as a key figure in the development of new medicinal compounds.
Collaborations
Cognacq has collaborated with notable individuals in his field, including Jean-Marie C Teulon and Bernard Schweisguth. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Jean-Claude Cognacq's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of medicinal chemistry and a dedication to enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile